These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32316679)
1. Tumor-Homing pH-Sensitive Extracellular Vesicles for Targeting Heterogeneous Tumors. Park J; Lee H; Youn YS; Oh KT; Lee ES Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32316679 [TBL] [Abstract][Full Text] [Related]
2. pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery. Lee H; Park H; Noh GJ; Lee ES Carbohydr Polym; 2018 Dec; 202():323-333. PubMed ID: 30287007 [TBL] [Abstract][Full Text] [Related]
3. Dendritic Cell-Targeted pH-Responsive Extracellular Vesicles for Anticancer Vaccination. Lee H; Park H; Yu HS; Na K; Oh KT; Lee ES Pharmaceutics; 2019 Jan; 11(2):. PubMed ID: 30691225 [TBL] [Abstract][Full Text] [Related]
4. Development of 5-Fluorouracil/pH-Responsive Adjuvant-Embedded Extracellular Vesicles for Targeting α Kim J; Lee E; Lee ES Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794261 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronated nanoparticles with pH- and enzyme-responsive drug release properties. Kim SW; Oh KT; Youn YS; Lee ES Colloids Surf B Biointerfaces; 2014 Apr; 116():359-64. PubMed ID: 24521699 [TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin's Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer. Jorquera-Cordero C; Lara P; Cruz LJ; Schomann T; van Hofslot A; de Carvalho TG; Guedes PMDM; Creemers L; Koning RI; Chan AB; de Araujo Junior RF Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631654 [TBL] [Abstract][Full Text] [Related]
7. A low-intensity focused ultrasound-assisted nanocomposite for advanced triple cancer therapy: local chemotherapy, therapeutic extracellular vesicles and combined immunotherapy. Tan M; Chen Y; Guo Y; Yang C; Liu M; Guo D; Wang Z; Cao Y; Ran H Biomater Sci; 2020 Dec; 8(23):6703-6717. PubMed ID: 33108411 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids. Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297 [TBL] [Abstract][Full Text] [Related]
9. Honeycomb-like pH-responsive γ-cyclodextrin electrospun particles for highly efficient tumor therapy. Yu HS; Lee ES Carbohydr Polym; 2020 Feb; 230():115563. PubMed ID: 31887908 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Loaded Extracellular Vesicles Enhance Tumor Cell Death in Retinoblastoma. Farhat W; Yeung V; Kahale F; Parekh M; Cortinas J; Chen L; Ross AE; Ciolino JB Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354582 [TBL] [Abstract][Full Text] [Related]
12. A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: in vitro evaluation. Oh NM; Oh KT; Baik HJ; Lee BR; Lee AH; Youn YS; Lee ES Colloids Surf B Biointerfaces; 2010 Jun; 78(1):120-6. PubMed ID: 20299192 [TBL] [Abstract][Full Text] [Related]
13. A Dual-Reporter Platform for Screening Tumor-Targeted Extracellular Vesicles. Kanada M; Linenfelser L; Cox E; Gilad AA Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335849 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539 [TBL] [Abstract][Full Text] [Related]
15. pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery. Qiu L; Zhu M; Gong K; Peng H; Ge L; Zhao L; Chen J Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():912-922. PubMed ID: 28576067 [TBL] [Abstract][Full Text] [Related]
16. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy. Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789 [TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. Rayamajhi S; Nguyen TDT; Marasini R; Aryal S Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363 [TBL] [Abstract][Full Text] [Related]
18. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles. Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485 [TBL] [Abstract][Full Text] [Related]
19. Microchip Based Isolation and Drug Delivery of Patient-Derived Extracellular Vesicles Against Their Homologous Tumor. Ge K; Ren Y; Hong Z; Mao Z; Yao B; Ye K; Jia C Adv Healthc Mater; 2024 Sep; ():e2401990. PubMed ID: 39221674 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of resazurin phenoxazine dye as a highly sensitive cell viability potency assay for natural killer cell-derived extracellular vesicle-based cancer biotherapeutics. St-Denis-Bissonnette F; Qiu S; Cummings SE; Kirkby M; Haile Y; Wassmer S; Muradia G; Mehic J; Stalker A; Shrestha A; Ardolino M; Lee SH; Burger D; Wang L; Lavoie JR J Extracell Biol; 2024 Jul; 3(7):e166. PubMed ID: 39022723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]